193700-51-5

Basic information

• Product Name: leridistim
• Synonyms: leridistim;SC-70935;14-125-Interleukin 3 (14-alanine) (human reduced) fusion protein with peptide (synthetic) fusion protein with granulocyte colony-stimulating factor (17-serine) (human reduced)
• CAS NO: 193700-51-5
• Molecular Weight: 0
• Mol File: 193700-51-5.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: leridistim(CAS DataBase Reference)
• NIST Chemistry Reference: leridistim(193700-51-5)
• EPA Substance Registry System: leridistim(193700-51-5)

Safety Data

• Hazardous Substances Data: 193700-51-5(Hazardous Substances Data)

Usage

Description

Leridistim is a multifunctional agonist that activates both interleukin-3 and G-CSF receptors. It is primarily used in the treatment of chemotherapy-induced neutropenia and thrombocytopenia, conditions characterized by a decrease in the number of neutrophils and platelets in the blood, respectively.

Uses

Used in Pharmaceutical Industry:
Leridistim is used as a therapeutic agent for the treatment of chemotherapy-induced neutropenia and thrombocytopenia. It helps in increasing the white blood cell count, particularly neutrophils, and platelet count in patients undergoing chemotherapy, thereby reducing the risk of infections and bleeding complications.
In addition to its primary use, Leridistim may also have potential applications in other areas of medicine, such as immunology and hematology, due to its ability to modulate immune cell function and promote blood cell production. However, further research and clinical trials are necessary to explore these potential applications fully.